185 related articles for article (PubMed ID: 18296890)
1. An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea.
Choi JG; Lee YJ; Kim YJ; Lee EK; Jeong OM; Sung HW; Kim JH; Kwon JH
J Vet Sci; 2008 Mar; 9(1):67-74. PubMed ID: 18296890
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
3. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
[TBL] [Abstract][Full Text] [Related]
4. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine.
Choi JG; Lee YJ; Kim JY; Kim YH; Paek MR; Yang DK; Son SW; Kim JH
J Vet Sci; 2010 Jun; 11(2):161-3. PubMed ID: 20458158
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
[TBL] [Abstract][Full Text] [Related]
7. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
[TBL] [Abstract][Full Text] [Related]
8. Inactivated H9N2 avian influenza virus vaccine with gel-primed and mineral oil-boosted regimen could produce improved immune response in broiler breeders.
Lee DH; Kwon JS; Lee HJ; Lee YN; Hur W; Hong YH; Lee JB; Park SY; Choi IS; Song CS
Poult Sci; 2011 May; 90(5):1020-2. PubMed ID: 21489949
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens.
Shin JH; Mo JS; Kim JN; Mo IP; Ha BD
J Vet Sci; 2016 Mar; 17(1):27-34. PubMed ID: 27051337
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
Park JK; Lee DH; Cho CH; Yuk SS; To EO; Kwon JH; Noh JY; Kim BY; Choi SW; Shim BS; Song MK; Lee JB; Park SY; Choi IS; Song CS
Vet Microbiol; 2014 Mar; 169(3-4):211-7. PubMed ID: 24472228
[TBL] [Abstract][Full Text] [Related]
11. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
12. Antigenic evolution of H9N2 chicken influenza viruses isolated in China during 2009-2013 and selection of a candidate vaccine strain with broad cross-reactivity.
Wei Y; Xu G; Zhang G; Wen C; Anwar F; Wang S; Lemmon G; Wang J; Carter R; Wang M; Sun H; Sun Y; Zhao J; Wu G; Webster RG; Liu J; Pu J
Vet Microbiol; 2016; 182():1-7. PubMed ID: 26711021
[TBL] [Abstract][Full Text] [Related]
13. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization with an attenuated
Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
[TBL] [Abstract][Full Text] [Related]
15. H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity.
Arai Y; Elgendy EM; Daidoji T; Ibrahim MS; Ono T; Sriwilaijaroen N; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641475
[TBL] [Abstract][Full Text] [Related]
16. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
Song H; Nieto GR; Perez DR
J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
[TBL] [Abstract][Full Text] [Related]
18. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
[TBL] [Abstract][Full Text] [Related]
19. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
